Thompson Siegel & Walmsley’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-500
Closed -$31K – 440
2023
Q4
$31K Hold
500
– – ﹤0.01% 439
2023
Q3
$29K Hold
500
– – ﹤0.01% 442
2023
Q2
$31K Hold
500
– – ﹤0.01% 442
2023
Q1
$36K Hold
500
– – ﹤0.01% 436
2022
Q4
$40K Hold
500
– – ﹤0.01% 429
2022
Q3
$33K Hold
500
– – ﹤0.01% 438
2022
Q2
$38K Hold
500
– – ﹤0.01% 429
2022
Q1
$40K Hold
500
– – ﹤0.01% 471
2021
Q4
$37K Hold
500
– – ﹤0.01% 488
2021
Q3
$34K Hold
500
– – ﹤0.01% 520
2021
Q2
$42K Buy
500
+250
+100% +$20.8K ﹤0.01% 512
2021
Q1
$20K Buy
+250
New +$21.3K ﹤0.01% 584

Other funds holding INCY

Thompson Siegel & Walmsley's INCY Position: Q1 2024 in Review

Thompson Siegel & Walmsley sold out of Incyte (INCY) in Q1 2024, closing a stake of 500 shares — an estimated $31K sold.

Thompson Siegel & Walmsley first reported a position in INCY in Q1 2021 and held it in 12 quarters. The position peaked at $42K in Q2 2021. 587 funds tracked by Wall St. Rank hold INCY as of Q1 2024.

  • Thompson Siegel & Walmsley reported no remaining Incyte position as of Q1 2024 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 500 Incyte shares in Q1 2024, an estimated $31K.
  • Thompson Siegel & Walmsley first reported a position in Incyte in Q1 2021 and held it in 12 quarters.
  • Thompson Siegel & Walmsley's Incyte position peaked at $42K in Q2 2021.
  • 587 funds tracked by Wall St. Rank held Incyte as of Q1 2024.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2024, filed 9 May 2024.